TrialBlood2025

A phase 2 trial of CHOP with anti-CCR4 antibody mogamulizumab for older patients with adult T-cell leukemia/lymphoma.

Makoto Yoshimitsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.